Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures

K Takeda1, A Hatamochi, M Arakawa

  • 1Department of Dermatology, Kawasaki Medical School, Kurashiki, Japan.

Insights

Tumor necrosis factor-alpha (TNF-alpha) reduces collagen production in systemic sclerosis (SSc) fibroblasts, suggesting potential therapeutic benefits for SSc treatment. This finding highlights TNF-alpha's role in regulating extracellular matrix components.

Area of Science:

  • Dermatology
  • Immunology
  • Molecular Biology

Background:

  • Systemic sclerosis (SSc) is marked by excessive collagen accumulation in the skin.
  • Tumor necrosis factor-alpha (TNF-alpha) influences collagen and matrix metalloproteinase production in fibroblasts.

Purpose of the Study:

  • To investigate the effects of TNF-alpha on collagen types I, III, VI, fibronectin, and collagenase gene expression in fibroblasts from normal individuals and SSc patients.
  • To assess the potential of TNF-alpha as a therapeutic agent for SSc.

Main Methods:

  • Cultured dermal fibroblasts from normal individuals and SSc patients were treated with TNF-alpha.
  • Gene expression levels for collagens I, III, VI, fibronectin, and collagenase were analyzed using mRNA analysis.
  • Collagenase activity was also measured.

Main Results:

  • TNF-alpha inhibited collagen I, III, and fibronectin production and mRNA levels in SSc fibroblasts.
  • TNF-alpha stimulated collagenase activity and mRNA levels in SSc fibroblasts.
  • Collagen VI mRNA levels (alpha 1 and alpha 3) and beta-actin mRNA were unaffected by TNF-alpha in both normal and SSc fibroblasts.

Conclusions:

  • TNF-alpha demonstrates potential as a beneficial treatment for SSc by reducing excessive collagen deposition.
  • Collagen VI expression is regulated independently of collagens I and III.
  • Fibronectin and collagen I/III expression are coordinately regulated by TNF-alpha in fibroblasts.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...